Medtronic plc (NYSE:MDT) Q2 2025 Earnings Conference Call November 19, 2024 8:00 AM ET
Company Participants
Ryan Weispfenning - VP and Head, IR
Geoff Martha - Chairman and CEO
Gary Corona - Interim CFO
Brad Welnick - VP, IR
Que Dallara - EVP and President, Diabetes Operating Unit
Sean Salmon - EVP and President, Cardiovascular Portfolio
Mike Marinaro - EVP and President, Medical Surgical Portfolio and Surgical Operating Unit
Brett Wall - EVP and President, Neuroscience
Conference Call Participants
Larry Biegelsen - Wells Fargo
Travis Steed - Bank of America
Robbie Marcus - JPMorgan
Vijay Kumar - Evercore ISI
Shagun Singh - RBC Capital Markets
Chris Pasquale - Nephron
Pito Chickering - Deutsche Bank
Anthony Petrone - Mizuho Securities
Rich Newitter - Truist Securities
Danielle Antalffy - UBS
Joanne Wuensch - Citi
Matt Miksic - Barclays
Patrick Wood - Morgan Stanley
Ryan Weispfenning
Good morning. I’m Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations and I appreciate that you’re joining us for our Fiscal '25 Second Quarter Video Earnings Webcast.
Before we go inside to hear our prepared remarks, I’ll share a few details about today’s webcast. Joining me are Geoff Martha, Chairman and Chief Executive Officer; and Gary Corona, Interim Chief Financial Officer. Geoff and Gary will provide comments on the results of our second quarter, which ended on October 25, 2024, and our outlook for the remainder of fiscal year 2025.
After our prepared remarks, the Executive VPs from each of our four segments will join us and will take questions from the sell-side analysts that cover the company. Today’s program should last about an hour.
Earlier this morning, we issued a press release containing our financial statements, divisional and geographic revenue summaries, and non-GAAP reconciliations. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press release or on our website at investorrelations.medtronic.com.
During today’s program, many of the statements we make may be considered forward-looking statements and actual results may differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause our actual results to differ is contained in our periodic reports and other filings that we make with the SEC and we do not undertake to update any forward-looking statement.
Unless we say otherwise, all comparisons are on a year-over-year basis and revenue comparisons are made on an organic basis, which excludes the impact of foreign currency and second quarter revenue in the current and prior year reported as other. References to sequential revenue changes compared to the first quarter of fiscal '25 and are made on an as-reported basis. All references to share gains or losses are on a revenue and year-over-year basis and compare our second fiscal quarter against our competitors’ third calendar quarter.